09 - 10 November 2022 | London, UK
+ Digital Day: 11 November 2022 | Online

Philip Beer

Vice President, Research and Translational Medicine and Honorary Professor, Translational Medicine
Step Pharma and Hull York Medical School
Philip Beer
Philip is a physician scientist with expertise in drug development and biomarker discovery. He followed his initial training as a haematologist with 8 years’ research in Cambridge and Vancouver, focused on understanding genotype-phenotype correlations in haematological cancers and developing improved preclinical models of leukaemia. Since then, Philip has worked cross-sector in academic, healthcare and biotech roles with a unified goal of accelerating oncology drug development and ensuring that each patient receives the most suitable therapy.  


No data was found

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.